Several groups have reported that MYCN and ALK gain-of-function mutations, either in locus or overexpressed, cooperate to drive transformation, and result in increased neuroblastoma penetrance in both cell line—mouse and zebrafish—models [46,57,58,59,60,62,63]. This evidence concerns the gene MYCN and neuroblastoma.